⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OCS News
Oculis Holding AG Ordinary shares
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis
globenewswire.com
OCS
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis
globenewswire.com
OCS
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis
globenewswire.com
OCS
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
globenewswire.com
OCS
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
globenewswire.com
OCS
Oculis to Participate in Upcoming Investor Conferences
globenewswire.com
OCS
Oculis to Participate in Upcoming Investor Conferences
globenewswire.com
OCS
Oculis to Participate in Upcoming Investor Conferences
globenewswire.com
OCS
Oculis to Participate in Upcoming Investor Conferences
globenewswire.com
OCS
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
globenewswire.com
OCS